Use of Proton-Pump Inhibitors Predicts Heart Failure and Death in Patients with Coronary Artery Disease-Reference-Cited by-同舟云学术

Use of Proton-Pump Inhibitors Predicts Heart Failure and Death in Patients with Coronary Artery Disease

Published:2017-01-19 Issue:1 Volume:12 Page:e0169826
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Pello Lázaro Ana María,Cristóbal Carmen,Franco-Peláez Juan Antonio,Tarín Nieves,Aceña Álvaro,Carda Rocío,Huelmos Ana,Martín-Mariscal María Luisa,Fuentes-Antras Jesús,Martínez-Millá Juan,Alonso Joaquín,Lorenzo Óscar,Egido Jesús,López-Bescós Lorenzo,Tuñón José

Funder

Fondo de Investigaciones Sanitarias

ISCIII-RETIC REDinREN

Comunidad de Madrid

Spanish Society of Cardiology

Spanish Heart Foundation

RECAVA

Instituto de Salud Carlos III FEDER

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference39 articles.

1. Famotidine is inferior to pantoprazole in preventing recurrence of aspirin-related peptic ulcers or erosions;F-H Ng;Gastroenterology,2010

2. Clopidogrel and proton pump inhibitors: influence of pharmacological interactions on clinical outcomes and mechanistic explanations;US Tantry;JACC Cardiovasc Interv,2011

3. Clopidogrel with or without omeprazole in coronary artery disease;DL Bhatt;N Engl J Med,2010

4. Research C for DE and. Postmarket Drug Safety Information for Patients and Providers—FDA Drug Safety Communication: Possible increased risk of fractures of the hip, wrist, and spine with the use of proton pump inhibitors. Center for Drug Evaluation and Research;

5. Proton pump inhibitors and risk of 1-year mortality and rehospitalization in older patients discharged from acute care hospitals;M Maggio;JAMA Intern Med,2013

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assessment of prescription pattern and impact of statin in lipid profile among ischemic heart disease patients;Journal of Education and Health Promotion;2024-06

2. Inhibitors of gastric acid secretion increase oxidative stress and matrix metalloproteinase-2 activity leading to vascular remodeling;Molecular and Cellular Biochemistry;2024-02-01

3. Association between Acid-Suppressive Drugs and Clinical Outcomes in Patients with Nonvalvular Atrial Fibrillation;Drugs in R&D;2022-07-19

4. Exposure to Proton Pump Inhibitors and the Risk of Incident Asthma in Patients with Coronary Artery Diseases: A Population-Based Cohort Study;Journal of Personalized Medicine;2022-05-19

5. Association of Proton Pump Inhibitors With Higher Risk of Cardiovascular Disease and Heart Failure;Mayo Clinic Proceedings;2021-10